Table 3.

SCD risk profile in HCM patients with or without HighT2/LGE

	LGE− and HighT2− (n = 35)	LGE+ and HighT2− (n = 42)	LGE+ and HighT2+ (n = 26)	p value
Risk category
ESC: intermediate-high SCD risk	1 (3%)	7 (17%)	8 (31%)	.012
ACC/AHA: intermediate-high SCD risk	5 (17%)	9 (21%)	11 (42%)	.035
Quantitative SCD risk
Estimated 5-year risk (%)	1.5 (1.1–1.9)	2.3 (1.4-3.0)	2.9 (1.6–4.3)	< .001

Data are presented as numbers (percentages) or medians (interquartile ranges)

LGE late gadolinium enhancement, HighT2 high signal intensity on T2-weighted imaging, SCD sudden cardiac death